Policy and Data Analyst

The National Association of Medicaid Directors (NAMD) is seeking a Policy and Data Analyst to serve as a critical addition to our staff. This individual will play a key role in the support of the NAMD Leadership Team and Board in the execution of projects and the development of policy statements, publications, newsletters and other strategic communications. NAMD is looking for an individual with strong skills in survey techniques, interpreting and managing survey results, and developing quantitative and qualitative information to support the work of NAMD and its member Directors.

NAMD is focused primarily on supporting the state Medicaid Directors both collectively through the use of consensus-based advocacy, as well as individually through best practices and technical assistance.

Roles and Responsibilities

The successful candidate will have demonstrated capacity to: interpret data in the use of policy development; work with a small team on multiple projects simultaneously; be flexible to accommodate the changing needs of a small organization. Specific responsibilities include:

  • Serve as Project Lead on the annual NAMD Operations Survey; including question design and formatting, survey administration and follow-up; analysis and synthesis of responses, and preparation of the annual report.
  • Develop, administer, analyze and report on ad hoc surveys of members on an as needed basis to inform NAMD policy discussions and positions.
  • Research issues related to the Medicaid program, with an emphasis on quantitative information pertaining to Medicaid policy and quality of care.
  • Assist NAMD staff in the development and visual display of quantitative information relevant to Medicaid Directors and stakeholders;
  • Abstract key data from results of outside surveys and secondary data and interpret for dissemination to NAMD members and stakeholders;
  • Other duties as assigned in support of NAMD activities; such as preparation for the semi-annual member meetings; preparation of policy documents, letters and reports; project management

Background, training and skills

  • Knowledge and background in the Medicaid program
  • Bachelor’s degree plus experience in health-related research and analysis; or Master’s degree in a health-related field and demonstrated basic quantitative analytic skills
  • Excellent written and oral communication skills
  • Ability to develop graphic displays of data in support of oral and written communications.
  • Strong project management skills and capacity to self-direct workflow.
  • Ability to work in a cooperative, team-oriented environment and to network with a wide-range of stakeholders.

Salary negotiable and commensurate with experience. No phone calls, please.

 

TO APPLY: Send resume, cover letter and salary history to:

Tess Moore, COO

National Association of Medicaid Directors

Tess.moore@medicaiddirectors.org

Thank you for joining us at the recent training on Federal Medicaid Authorities hosted by the CMS Boston Regional Office and the New England States Consortium Systems Organization (NESCSO). Please follow the link to the slides presented at the meeting: SPA Training 2016 FINAL2

Travel reimbursement for each state is being provided by NESCSO.  Please see the travel documents that are needed for reimbursement through NESCSO. Please complete these forms and mail them with your original detailed receipts to NESCSO, 333 South Street, Shrewsbury, MA 01545.

NESCSO Nonemployee reimbursement voucher 030716

UMW-9

Please contact David Huffman at David.Huffman@umassmed.edu (508) 856.6425 or Katie Holt at kathryn.holt@cms.hhs.gov  (617) 565-1246  if you have any questions.

 

For Immediate Release January 27, 2016

Contact: Communications Office (603)271-2121

CONCORD – Following today’s bipartisan vote by the Executive Council to confirm Jeffrey Meyers of Concord as Commissioner of the Department of Health and Human Services, Governor Maggie Hassan issued the following statement:

“Jeffrey Meyers is vastly experienced in working with all relevant stakeholders to develop and implement complex health care initiatives, and I applaud the Executive Council for their bipartisan confirmation vote. As Commissioner of the Department of Health and Human Services, Jeff’s leadership will be critical to reauthorizing and continuing the success of our bipartisan health care expansion plan and strengthening our efforts to combat substance abuse. I thank Jeff for his willingness to accept the important responsibility of leading our state’s largest department, and I look forward to continuing to work with him, members from both parties and people throughout the medical community on the priorities that are critical to the health and well-being of our people and families.”

Follow the link to the Concord Monitor for the most recent news as of January 5, 2016: Jeffrey Meyers – Concord Monitor 010516

The New England States Consortium Systems Organization (NESCSO) announces the appointment of Elena Nicolella as the organization’s new executive director. An accomplished health and human service expert, she has experience in both state and federal government in the management and financing of Medicaid programs, most recently serving in Rhode Island’s Office of Policy and Innovation. A graduate of New York University, Nicolella holds a Master’s in Public Health from Boston University.

In making the announcement, Daniel Tsai, the NESCSO board chairman and assistant secretary of the Executive Office of Health and Human Services for Massachusetts, cited Nicolella’s background and deep understanding of the complexities of state human service and Medicaid programs. “NESCSO is fortunate to have a professional with the experience Elena brings. From her relationship with the Centers for Medicare and Medicaid Services (CMS) and the staff there, to having served as the Rhode Island Medicaid director, Elena will truly be a colleague to the NESCSO board members,” he said.

Nicolella takes over the position from Brenda Harvey, who is retiring after five years as the executive director. Harvey was instrumental in helping NESCSO and its member states maintain their focus as many aspects of the Affordable Care Act were implemented. She also spurred collaboration among states in developing approaches to address behavioral health and substance abuse with the aid of CMS and the Substance Abuse and Mental Health Services Administration, and expanded the scope and reach of the national Medicaid Enterprise Systems Conference.

Please see the travel documents that will be needed for reimbursement through NESCSO. Please complete the Pre-travel Authorization Form and send a scanned copy to info@nescso.org at your earliest convenience.

NESCSO SOC Pre-Travel Authorization_final 050916

NESCSO Nonemployee reimbursement voucher SOC Symposium 2016

UMW-9

 

Hotel Information:

Please note that the deadline for our guaranteed rate at the Inn at the Colonnade is approaching. In order to secure the $149/night rate, please be sure to book by Friday, May 13. The links to the room block reservation page and the hotel site are provided below.

SOC Room Block Link

Hotel Link: Inn at The Colonnade Baltimore – a DoubleTree by Hilton Hotel

Address: 4 West University Parkway, Baltimore, MD 21218-2306

Phone: 410-235-5400

Please contact Gillian Tucker (gillian@stewardsofchange.com) with questions on Symposium hotel arrangements.  Thank you!

Boston, Mass., November 24, 2015 – The Institute for Clinical and Economic Review (ICER) has posted the final report PCSK9 Inhibitors for Treatment of High Cholesterol: Effectiveness, Value, and Value-Based Price Benchmarks, and its accompanying Action Guides to the New England Comparative Effectiveness Public Advisory Council website. This final report is an update to ICER’s earlier draft report on the two PCSK9 inhibitors approved by the FDA earlier this year: Alirocumab (Praluent®, Regeneron/Sanofi) and evolocumab (Repatha™, Amgen).  The final report incorporates the results of the deliberation and voting on the strength of evidence by the New England Comparative Effectiveness Public Advisory Council (New England CEPAC).  In addition, the final report includes an updated value-based price benchmark for PCKS9 inhibitor drugs and policy recommendations for coverage policy and for clinical practice generated by discussion with clinical experts, payers, patients, and other stakeholders at the public meeting of the New England CEPAC.  To accompany the final report ICER has released an Action Guide for policymakers and clinicians, as well as a separate guide for patients. The Action Guides further distill key policy recommendations and provide resources to support their implementation.